Plasmatic Membrane Expression of Adhesion Molecules in Human Cardiac ProgenitorStem Cells Might Explain Their Superior Cell Engraftment after Cell Transplantation

Abstract EN

Human bone marrow mesenchymal stem cells (BM-MSCs) and cardiac progenitor/stem cells (CPCs) have been extensively studied as a potential therapeutic treatment for myocardial infarction (MI).

Previous reports suggest that lower doses of CPCs are needed to improve cardiac function relative to their bone marrow counterparts.

Here, we confirmed this observations and investigated the surface protein expression profile that might explain this effect.

Myocardial infarction was performed in nude rats by permanent ligation of the left coronary artery.

Cardiac function and infarct size before and after cell transplantation were evaluated by echocardiography and morphometry, respectively.

The CPC and BM-MSC receptome were analyzed by proteomic analysis of biotin-labeled surface proteins.

Rats transplanted with CPCs showed a greater improvement in cardiac function after MI than those transplanted with BM-MSCs, and this was associated with a smaller infarct size.

Analysis of the receptome of CPCs and BM-MSCs showed that gene ontology biological processes and KEGG pathways associated with adhesion mechanisms were upregulated in CPCs compared with BM-MSCs.

Moreover, the membrane protein interactome in CPCs showed a strong relationship with biological processes related to cell adhesion whereas the BM-MSCs interactome was more related to immune regulation processes.

We conclude that the stronger capacity of CPCs over BM-MSCs to engraft in the infarcted area is likely linked to a more pronounced cell adhesion expression program.